Centiva Capital’s Compugen CGEN Stock Holding History

Centiva Capital’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,703	Closed	-$105K	–	1307
2021 Q2	$105K	Buy	+12,703	New	+$103K	﹤0.01%	1258

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Centiva Capital's CGEN Position: Q3 2021 in Review

Centiva Capital sold out of Compugen (CGEN) in Q3 2021, closing a stake of 12,703 shares — an estimated $105K sold.

Centiva Capital first reported a position in CGEN in Q2 2021 and held it in 1 quarter. The position peaked at $105K in Q2 2021. 108 funds tracked by Wall St. Rank hold CGEN as of Q3 2021.

Centiva Capital reported no remaining Compugen position as of Q3 2021 after selling out during the quarter.
Centiva Capital sold 12,703 Compugen shares in Q3 2021, an estimated $105K.
Centiva Capital first reported a position in Compugen in Q2 2021 and held it in 1 quarter.
Centiva Capital's Compugen position peaked at $105K in Q2 2021.
108 funds tracked by Wall St. Rank held Compugen as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.